Results 101 to 110 of about 57,421 (320)
Healthcare utilization and costs among patients with acromegaly in the United States
Aim: Recent evidence regarding the healthcare resource utilization (HCRU) and associated costs of acromegaly is limited. Materials & methods: This retrospective, cross-sectional administrative claims analysis (IQVIA Pharmetrics Plus) identified ...
Tiffany P Quock+8 more
doaj +1 more source
Long‐standing growth hormone (GH) excess causes the skeletal clinical signs of acromegaly with typical changes in bone geometry, including increased cortical bone thickness (CBT).
Kristin Godang+8 more
doaj +1 more source
Acromegaly and hypertension [PDF]
Acromegaly is usually caused by pituitary adenomas that secrete growth hormone (GH). The disease is prone to be complicated with hypertension and thus aggravates the state of the illness and increase the disease burden.
WANG Shu-chang, ZHU Hui-juan, PAN Hui
doaj
Aneurysmal dilation of sinus of Valsalva in a patient with undiagnosed acromegaly
Key Clinical Message In patients presenting with aortic ectasia and myxomatous valve diseases at young ages, possible underlying acromegaly should be in mind. Abstract Acromegaly is a chronic systemic disease mainly caused by the benign pituitary adenoma
Hoda Gharoy+4 more
doaj +1 more source
Adiponectin and Cardiac Hypertrophy in Acromegaly [PDF]
Background. Adiponectin is an adipocytes-derived hormone which has been shown to possess insulin-sensitizing, antiatherogenic, and anti-inflammatory properties. In acromegaly, the data on adiponectin is contradictory. The relationship between adiponectin
Akdag, B+7 more
core +2 more sources
Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms
Abstract Neuroendocrine neoplasms (NEN) themselves and also their treatment may cause malnutrition, inducing changes in physiological behaviour and eventually leading to increased rates of morbidity and mortality. Malnutrition is a common, under‐recognised and under‐treated condition in patients with NEN, and there are limited data available on the ...
Simona Grozinsky‐Glasberg+53 more
wiley +1 more source
Biomarkers of acromegaly [PDF]
The papers of Kiseljak-Vassiliades et al. [1] and Selek et al. [2] published in this issue are significant because they focus on an important and unresolved problem of pituitary tumor prognosis, progression, and treatment. Many years ago, pituitary tumors were classified based only on their tinctorial properties using the hematoxylin—eosin stain and ...
Kalman Kovacs+2 more
openaire +2 more sources
Clinical and economic burden among older adults with acromegaly in the United States
Aim: To compare healthcare resource utilization (HCRU) and costs between older adults with and without acromegaly. Materials & methods: Using 2017–2022 100% Medicare Research Identifiable Files, we identified beneficiaries (≥65 years) with prevalent ...
Tiffany P Quock+7 more
doaj +1 more source
Abstract Tumor‐infiltrating immune cells (TICs) are important components of the tumor microenvironment (TME). They regulate somatotroph adenoma treatment responses to therapy with somatostatin receptor ligands (SRLs), mediated by soluble factors and cytokines. In this study, we assessed the effect of SRLs treatment on TICs.
Sabrina Chiloiro+16 more
wiley +1 more source
Objectives To evaluate the glomerular ultrastructural changes associated with diabetic nephropathy and quantify glomerular vascular endothelial growth factor‐A expression in cats with diabetes mellitus compared to controls. Materials and Methods Transmission electron microscopy was performed to evaluate glomerular ultrastructural changes, including ...
H. Reyes‐Hughes+6 more
wiley +1 more source